India, June 12 -- Shares of ReShape Lifesciences Inc. (RSLS) gained over 25% on Thursday morning after the health solutions company signed exclusive distribution agreement with Recon Supply to access the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems.
RSLS is currently trading at $2.9050, up $0.6150 or 26.9147%, on a huge volume of 75 million shares, above average volume of 1.7 million, on the Nasdaq. The stock opened its trading at $2.9500 after closing Wednesday at $2.2900. The stock has traded between $2.2300 and $414.7000 in the past 52-week period.
ReShape Lifesciences signed an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribut...